Regenlab USA Inc.
- Ticker
- RGNA
- CIK
- 2084031
- Industry
- Pharmaceutical Preparations
Prospectus 7
- FWP Filing under Securities Act Rules 163/433 of free writing prospectuses
- S-1/A General form of registration statement for all companies including face-amount certificate companies
- S-1 General form of registration statement for all companies including face-amount certificate companies
- DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
- DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
- DRS/A Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
- DRS Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy